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Abstract
Background: Axillary lymphadenectomy or sentinel biopsy is integral part of breast cancer treatment, yet seroma
formation occurs in 15-85% of cases. Among methods employed to reduce seroma magnitude and duration, fibrin
glue has been proposed in numerous studies with controversial results.
Methods: Thirty patients over 60 years underwent quadrantectomy or mastectomy with level I/II axillary
lymphadenectomy; a suction drain was fitted in all patients. Fibrin glue spray were applied to the axillary fossa in
15 patients; the other 15 patients were treated with harmonic scalpel.
Results: Suction drainage was removed between post-operative Days 3 and 4. Seroma magnitude and duration
were not significant in patients receiving fibrin glue compared with the harmonic scalpel group.
Conclusions: Use of fibrin glue does not always prevent seroma formation, but can reduce seroma magnitude,
duration and necessary evacuative punctures.
Background
Axillary dissection represents an integral part of the
treatment for breast cancer for prognostic and curative
purposes. There is still a significant incidence (15-81%)
of complications associated with axillary lymphadenect-
omy, including lymphorrhea, lymphoceles, and in rare
cases lymphedema (swelling of the arm) [1-5]. It is pos-
sible to avoid axillary dissection in selected patients (T1
N0) using the sentinel lymph node technique. However,
in all cases where T > 3 cm, and in patients with T1 N1
or with a metastatic sentinel lymph node, conventional
axillary lymphadenectomy remains the primary surgical
protocol for quadrantectomy and mastectomy. Many
different methodologies have been used in an effort to
reduce seroma formation following axillary lymphade-
nectomy for breast cancer. These include suction drai-
nage [6,7] topical application of tetracycline [8], closing
and stitching the axillary fossa [9,10], axillary dissection
with axilloscopy [11], external compression [12,13], use
of harmonic scalpel and application of fibrin glue
[14,15]. To date, no practical guidelines exist on how to
conduct suction drainage, and the views of surgeons are
varied. Some surgeons believe that it is best to remove
the drain on the first day of the post-operative period,
some think the drain should be left in place until the
drained volume falls below 50 ml/day [16], while others
feel that drainage could in fact prolong and intensify the
inflammatory stage of the wound-healing process, with a
subsequent increase in seroma formation [17]. Regard-
less of contradicting opinions, the possibility of reducing
the time for which drainage is present during the recov-
ery period, therefore eliminating the need to discharge
patients with drainage in situ, may represent a valid
solution for reducing seroma formation. This prospec-
tive study evaluates the effectiveness of using fibrin glue
to reduce seroma formation following axillary lymphade-
nectomy for breast cancer.
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Methods
Between January 2010 and December 2012, 30 patients
over 60 years were enrolled in the study. All patents had
N+ breast adenocarcinoma and required either a quad-
rantectomy or a modified radical mastectomy with level
I or II axillary lymphadenectomy, extending from the
lower border of the axillary vein superiorly, from the
medial border of the smaller pectoral muscle medially,
as far as the fourth intercostobrachial nerve inferiorly
and to the edge of the latissimus dorsi laterally. The
axillary lymphadenectomy was performed in 15 patients
with ligations, scissors and electrocautery and in
15 patients with ultrasound scalpel [18]. To be enrolled
in the study, patients were required to have no altera-
tions in their blood clotting or immune systems, or at
least not be receiving anticoagulant treatment; have no
history of sensitisation to bovine aprotinin; no psycholo-
gical changes; no uncompensated diabetes or advanced
liver disease; not be severely obese, and not have had
previous surgery on the axillary lymphatic system or any
immediate reconstructive surgery. Short-term antibiotic
prophylaxis was applied. After surgery, all patients were
fitted with a suction drain at the axillary fossa, which
was activated 10 minutes after stitching the skin. The
harmonic scalpel group received the suction drain with-
out additional treatment, while the other group received
fibrin glue (Tisseal®/Tissucol®, Baxter Healthcare Cor-
poration, Deerfield, IL, USA). For patients in the fibrin
glue treatment group, following fitting of the drain,
fibrin glue prepared with 500 IU/ml of thrombin was
applied as a spray (2 ml, from a distance of 10 cm with
2 bars of pressure) at the site of the quadrantectomy or
mastectomy. Fibrin glue prepared with 5 IU/ml of throm-
bin was also applied as a spray (2 ml) to the axillary fossa
with approximately three minutes’ manual compression.
A compression dressing was applied over the treatment
site and kept in place for at least 24-72 hours. Fibrin glue
for the axillary fossa was prepared by diluting it to 5 IU/ml
with calcium chloride solution (20 mM), a concentration
capable of maintaining activation of the wound-healing
process through a thick mesh of fibrin fibrils. Patients
were discharged when the volume drained fell below
100 ml/day and suction drainage could be removed. One
week later, patients underwent clinical and instrumental
(ultrasound) assessment for the presence of seroma, and
any residue was suctioned out using an echo-guided eva-
cuative puncture, as necessary. The primary outcome mea-
sures of the study were a) the incidence of seroma,
including total volume of serum drained, and b) number
of evacuative punctures required. A secondary outcome
measure of the study was the duration of the treatment up
to the time of healing. Complications associated with the
axillary lymphadenectomy procedure were also recorded.
Statistical analysis was performed on the patients who
completed the postoperative evaluation using SPSS for
Windows (version 17.0; SPSS, Inc., Chicago, IL). Results
were expressed as mean ± SD unless otherwise indi-
cated. Continuous variables were compared by Student
t test and dichotomic variables were compared by the
chi-squared test and the McNemar test. P value < 0.05
was considered statistically significant.
Results
Factors as age, size of tumors and its ratio to the residual
breast volume following surgery, the number of lymph
node removed and the number of metastatic lymph
nodes, also did not represent significant variables in
terms of seroma magnitude. All patients were discharged
3-4 days following surgery. Compared with patients in
the control group, patients in the fibrin glue group had a
lower drainage volume 150 [60-350] versus 180 [110-400]
ml; p = NS), fewer evacuative punctures (2 [0-3] versus 3
[1-3]), and a not significantly reduced mean seroma dura-
tion i.e. healing time 12 [4-21]versus 14 (4-25) days; p =
NS). The incidence of complications was 20% (3 with cel-
lulitis) and 20% (2 with cellulitis and 1 with wound dia-
stasis) in patients who underwent surgery with and
without fibrin glue, respectively. No significant relation-
ship was observed in either patient group, between the
magnitude of seroma formation and the type of surgical
procedure (quadrantectomy or mastectomy) conducted.
Discussion
Breast cancer surgery, and in particular axillary lympha-
denectomy, has changed in the last few years with the
advent of the sentinel lymph node technique [11]. How-
ever, even today there are a number of situations where
a conventional axillary lymphadenectomy is indicated,
including patients with tumours greater than 3 cm in
diameter, with positive or suspect axillary lymph nodes
based on an objective examination and an instrumental
diagnosis, or with a positive sentinel lymph node. In this
group of patients, the axillary lymphadenectomy still has
complications, in particular seroma formation (15-81%)
[1-5], which can delay the patient’s discharge, healing
and supplementary radiotherapy and chemotherapy
treatments. The formation of seroma can result from a
lesion of the axillary lymphatic vessels [2] or from an
inflammatory reaction [17], which may also be pro-
longed and intensified by the continuance of suction
drainage. The removal of drainage for some surgeons is
indicated when the volume per day is less than 50 ml2,
but we prefer to remove the drainage when the volume
per day is less than 100 ml, since in our experience
drains do not prevent seroma formation, and they also
dictate the date of discharge, resulting in a longer stay
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[3]. A number of surgeons believe that it is possible to
discharge patients with the drainage in situ [3] despite
the associated discomfort and increase in percentage
infection rate. This issue of drainage management in the
home arises in cases of procedures carried out in day
surgery. Many published articles on the usefulness of
drainage following axillary lymphadenectomy contradict
each another with regard to seroma control, magnitude
and duration. Porter17reported a non-significant differ-
ence in the incidence and degree of seroma between
patients with suction drainage (73%) versus patients
without suction drainage (89%). Divino [4] reported a
6% incidence of seroma for patients with drainage, com-
pared with 40% for patients without. Burak [19] noted a
relationship between seroma magnitude and patient age.
Jeffrey [20] reported a 92% seroma incidence in patients
without drainage, and sharing the view of others that
repeated suctions may be the cause of infections of the
axillary fossa [21-25], applied evacuative puncture only
in symptomatic cases (42%). In terms of the methods of
reducing seroma magnitude, there have been numerous
reports of the benefits of using an external compression
dressing [26], immobilization of the arm [27], use of
sutures to close the axillary fossa [28], excessive use of
the electric scalpel compared to ligature of the lympha-
tic branches [29,30], benefits of multiple drains[21], and
the type of suction (high- or low-pressure) applied [31].
The use of fibrin glue has also produced contrasting
results: reduction of seroma according to Moore and
Gilly [11,26] no difference in seroma formation com-
pared with patients treated without fibrin glue, according
to Burak [19], Langer [27] and Dinsmore [28]. The latter
Authors attributed the lack of benefit to the presence of
drainage possibly interfering with the stabilization of a
fibrin clot, and with closure of the lymphatic capillaries.
Fibrin glue interacts with the tissues damaged during the
surgical procedure, favoring the growth of fibroblasts and
wound healing. It favors hemostasis by preventing hema-
tomas, which delay the surgical healing processes; makes
the lymphatic branches impermeable, reducing seroma
formation; and makes it possible to close the dead spaces
through tissue adhesion. A number of papers have pre-
sented comparative studies of patients with and without
fibrin glue in the axillary fossa. In a study of 24 patients
who underwent quadrantectomy or mastectomy with
axillary lymphadenectomy, In a group of 20 patients who
underwent quadrantectomy with axillary lymphadenect-
omy, Jain [29] reported a seroma incidence of around
40%, with a reduction in seroma magnitude in mastect-
omy patients upon whom fibrin glue was used. Although
a significant difference was not observed between quad-
rantectomy patients treated with or without fibrin glue.
The study demonstrated that suction drainage did not
limit the incidence or magnitude of seromas, and that it
was associated with extended time spent in hospital and
post-operative pain. Soon [30] showed that, among
patients who underwent quadrantectomy or mastectomy
with axillary lymphadenectomy, there was no difference
in terms of the incidence of seromas with or without the
use of suction drainage, and that, for the group of
patients without drainage, the seromas formed in greater
magnitude and for a longer duration, but with a lower
percentage of complications. Kuroi [31] in a Medline
search about one meta-analysis, 51 randomized con-
trolled trials, 7 prospective studies and 7 retrospective
studies showed that there was moderate evidence to sup-
port a risk for seroma formation in individuals with hea-
vier body weight, extended radical mastectomy and
greater drainage volume in the initial 3 days; with regard
to the use of adhesive glue many retrospective studies
failed to show any significant effect on seroma formation.
Based on our experience and reviewing data from the lit-
erature [3,10,21,31-37], it seems that the magnitude and
duration of the seromas are limited, but they are present
in over 80% of patients, without significant differences
between mastectomy and quadrantectomy. Use of har-
monic scalpel can reduce the magnitude of seromas and
acute blood loss after axillary dissection [38-48]. The use
of fibrin glue may therefore be useful, in our opinion, in
traditional breast cancer surgery for reducing seroma
magnitude and duration, and shortening the stay in hos-
pital which, in this pathology too, is increasingly con-
ducted in day surgery.
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